Infusion seems the popular consensus, but I'm not sure how much profit it actually turns. That's the real question.
If it were highly profitable you would have thought it would have been sold off a while ago, to avoid the first CR they promised would no longer be needed. For senior management they must have known this cash problem was coming for quite some time, which begs the question how did we come to this point.
- Forums
- ASX - By Stock
- CR and asset sale
Infusion seems the popular consensus, but I'm not sure how much...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$13.14 |
Change
0.140(1.08%) |
Mkt cap ! $277.7M |
Open | High | Low | Value | Volume |
$13.20 | $13.50 | $13.14 | $559.5K | 42.05K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1180 | $13.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.35 | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 680 | 13.000 |
1 | 1000 | 12.950 |
2 | 67 | 12.900 |
1 | 1000 | 12.800 |
1 | 37 | 12.000 |
Price($) | Vol. | No. |
---|---|---|
13.350 | 500 | 1 |
13.500 | 2000 | 1 |
13.510 | 46 | 1 |
13.900 | 300 | 1 |
14.440 | 25 | 1 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
NEWS
Biotech innovator secures $5.5M R&D tax incentive refund – major boost for cutting-edge programs
NEWS
Exceptional lithium assays uncovered at Falcon Lake – expanding mineralisation, big potential ahead
AVR (ASX) Chart |